4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-036573
Chief Medical Officer sold 6,578 shares at $9.50 ($62,491)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Karlin Dan Chief Medical Officer | 2024-03-25 | Sale 10b5-1 | −6,578 | $9.50 | $62,491 | 358,452 | D |
| Open-market sales · 6,578 sh · avg $9.50 · $62,491 | |||||||
Loading xslF345X05/ownership.xml…